Retatrutide – 10MG

$149.00

Buy Retatrutide in Canada — a next-generation triple agonist (GLP-1 / GIP / glucagon) studied for strong effects on metabolism and weight. ≥99% purity, HPLC-tested. For licensed research use only.

Save when you buy in bulk!

  • Spend $250Get 10% off
  • Spend $500Get 15% off
  • Spend $1,000Get 20% off

Earn 745 Points when you buy this item.

SKU: REV-RETATRUTIDE-10MG Categories: ,

Why Buy Retatrutide?

Retatrutide is one of the most complete metabolic research peptides available — it switches on three receptors (GLP-1, GIP, and glucagon) in a single molecule. In a Phase 2 trial, adults with obesity lost about 24% of their body weight after 48 weeks, the largest drop reported for this class so far.[1] Reviv Peptides ships it at ≥99% purity, HPLC-tested, with a Certificate of Analysis (COA) on request.

Retatrutide Benefits & Uses

Labs study Retatrutide mainly for weight and metabolism. Because it turns on three receptors at once, researchers use it to look at:

  • Triple receptor (GLP-1 / GIP / glucagon) signaling
  • Obesity and belly-fat models
  • Appetite and food-intake studies
  • Insulin sensitivity and blood-sugar control
  • Energy burn (thermogenesis) through glucagon activation
  • Heart and metabolic risk-factor studies
  • Side-by-side tests with Tirzepatide and Semaglutide

These uses come from published clinical and review research on Retatrutide and related incretin peptides.[1][2] Sold for licensed research use only.

How Retatrutide Works

Retatrutide works by turning on three hunger- and energy-related receptors at the same time. The GLP-1 part lowers appetite and slows the stomach. The GIP part helps the body release insulin and handle fat. The glucagon part raises how many calories the body burns and helps the liver use fat for fuel — a step that Semaglutide and Tirzepatide do not have.[1]

Retatrutide 10mg Vial Specifications

Here are the basic facts for the 10 mg vial.

  • Receptor targets: GLP-1, GIP, and glucagon (triple agonist)
  • Purity: ≥99% (third-party HPLC tested)
  • Form: Freeze-dried (lyophilized) powder
  • Vial size: 10 mg
  • Storage: −20 °C for long term; 4 °C for short term
  • Mixing: Bacteriostatic water

Why Choose Reviv Peptides?

Choose Reviv Peptides because every vial is third-party tested for identity and purity before it ships, with a COA available on request. We are one of the few Canadian suppliers that stocks Retatrutide, and we ship it discreetly across Canada in cold-chain-ready packaging.

Retatrutide Canada FAQs

How does Retatrutide compare to Tirzepatide?

Retatrutide adds a third receptor that Tirzepatide does not have. Tirzepatide works on two receptors (GLP-1 and GIP). Retatrutide adds glucagon, which raises energy burn. In Phase 2 studies, Retatrutide led to a bigger average weight drop (about 24%) than Tirzepatide (about 21%).[1]

What makes Retatrutide different from Semaglutide?

Retatrutide hits three receptors; Semaglutide hits one. Semaglutide works on GLP-1 only. Retatrutide works on GLP-1, GIP, and glucagon together, so labs study it for stronger effects on appetite, insulin, and energy burn.

Is Retatrutide available in Canada?

Yes. Reviv Peptides stocks Retatrutide and ships it across Canada for research use.


Reconstitution & Dosing Guide

Here is how to mix and store the vial for research.

How to Reconstitute

Add 1.0 mL of bacteriostatic water to the vial. Pour the water slowly down the inside wall — do not aim it at the powder. Swirl gently until it fully dissolves; do not shake. This makes about 10.0 mg/mL. Keep the mixed vial at 4 °C and use it within 28 days.

Low Starting Dose

A common research starting point is a low weekly amount.

  • Amount per injection: 2 mg (2,000 mcg) — 20 units (0.20 mL) on a U-100 syringe
  • How often: Once a week, under the skin
  • Length: At least 24 weeks

Start at the lowest useful dose and adjust to the response seen. This product is for laboratory research only.

Sources: [1] Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — a Phase 2 trial — NEJM / PubMed, 2023. [2] Retatrutide review — NIH / PMC.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide – 10MG”

Your email address will not be published. Required fields are marked *

RELATED PRODUCTS